ORBUS THERAPEUTICS LIMITED

Overview

Orbus Therapeutics Limited is a company based in Ireland, dedicated to developing treatments for rare diseases, particularly those affecting small patient populations. The company focuses on bringing innovative therapies to patients with life-threatening or significantly life-altering conditions. It is currently developing and commercializing eflornithine, a treatment for rare diseases, with clinical work including a STELLAR study on patients with grade 3 astrocytoma, completed in 2024. The name suggests a focus on rare disease therapeutics, with an emphasis on improving patient outcomes and quality of life. The company operates in the pharmaceutical and rare disease treatment sector. Information is available on its website, including leadership, clinical results, and patient-focused initiatives. Beyond registry-level identification, no further business details are publicly captured.

Location & registered address

70 Sir John Rogerson'S Quay

D02 R296

Dublin 2

Dublin 2

Dublin

Ireland

Industry classification

NACE Rev. 2 — 86.22

→ All NACE 86.22 companies in Ireland · In Dublin